Tuesday, Feb 3, 2026 · SEC filings
What the smart money revealed on Feb 3
1,395 insider filings came in. We hid 75 planned (10b5-1) sellers and 1,178 people whose filings were routine, like grants and tax withholding.
Zenas BioPharma (ZBIO) CEO Leon Moulder bought $1.02M
57,000 shares on the open market. Not a grant or an option exercise. Their past buys: 3 of 5 checked quarters beat the typical stock 6 months later.
StepStone Private Equity Strategies Fund Director Thomas Sittema bought $900K
80,976 shares on the open market. Not a grant or an option exercise.
StepStone Private Infrastructure Fund (STRUX) Director Thomas Sittema bought $750K
50,676 shares on the open market. Not a grant or an option exercise.
DXC Technology (DXC) President and CEO Raul Fernandez bought $251K
16,446 shares on the open market. Not a grant or an option exercise.
Fortinet (FTNT) VP Michael Xie sold $27.9M
Not marked as a planned 10b5-1 sale. Sold 3% of the shares they held directly. Still holds 10.21M shares.
Celestica (CLS) President Todd Cooper sold $25.7M
Not marked as a planned 10b5-1 sale. Sold 45% of the shares they held directly. Still holds 108,970 shares.
Celestica (CLS) Chief Operations Officer Yann Etienvre sold $24.8M
Not marked as a planned 10b5-1 sale. Sold every share held directly.
Show 25 more real buys
Show 86 more real sales
13F season
Holdings as of Dec 31, 2025 are due Feb 17
320 funds have filed so far. 81 filed for the quarter before.
Biggest real insider buys this week
Open-market buys by officers and directors, filed in the 7 days up to Feb 3.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.